REDWOOD CITY, Calif.--(BUSINESS WIRE)--Proteus Biomedical Inc., a pioneer in intelligent medicine, announced today that Chris Brinsmead has joined the company as Chairman, Proteus Biomedical Europe. Brinsmead has over 30 years of experience in the global pharmaceutical industry and more recently advising the United Kingdom government on health and life sciences policy. He will be instrumental in guiding the commercial launch of Proteus’s first product, Helius™, and the development of Proteus’s organization in Europe.
